Literature DB >> 10063918

Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat.

M Giralt1, P Vergara.   

Abstract

The aim of this study was to determine the mechanisms implicated in the gastrointestinal inhibition induced by ovoalbumin hydrolysate infused intraluminally. We studied the site of action, the possible implication of GLP-1, and the nervous mechanisms involved. We prepared anesthetized Sprague-Dawley rats with strain gauges in the antrum, duodenum, and proximal jejunum and a catheter in the duodenum or ileum for peptone infusion. Both intraduodenal (N = 6) and intraileal (N = 5) infusion of ovoalbumin hydrolysate induced inhibition of spontaneous motor activity in the antrum, duodenum, and proximal jejunum. Duodenal inhibition induced by intraduodenal (N = 6) or intraileal (N = 6) infusion of ovoalbumin hydrolysate was reversed by intraarterial infusion of GLP-1 receptor antagonist, exendin (9-39) (3 x 10(-8) mol/kg/40 min). Finally, a combination of the adrenergic blockers phentolamine and propranolol (1 mg/kg, each; N = 7) completely blocked inhibitory gastrointestinal motor actions caused by intraduodenal infusion of ovoalbumin hydrolysate. This study demonstrates that peptone, intraluminally infused, participates in the regulation of gastrointestinal motility through stimulation of adrenergic pathways in anaesthetized rats. Moreover, these effects are partly mediated by GLP-1 secretion. The ileum seems to be the site of action, indicating a role of GLP-1 on the ileal break mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10063918     DOI: 10.1023/a:1026654417697

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

2.  Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.

Authors:  J Schirra; P Kuwert; U Wank; P Leicht; R Arnold; B Göke; M Katschinski
Journal:  Proc Assoc Am Physicians       Date:  1997-01

3.  Effect of oleic acid on canine gastroduodenal motility, pyloric diameter and gastric emptying.

Authors:  O Keinke; H J Ehrlein
Journal:  Q J Exp Physiol       Date:  1983-10

4.  Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY.

Authors:  L Pironi; V Stanghellini; M Miglioli; R Corinaldesi; R De Giorgio; E Ruggeri; C Tosetti; G Poggioli; A M Morselli Labate; N Monetti
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

5.  Intestinal motility after infusion of arachis oil into duodenum and ileum of dogs.

Authors:  C Eeckhout; I De Wever; G Vantrappen
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

6.  Correlation between peptide YY-induced myoelectric activity and transit of small-intestinal contents in rats.

Authors:  A Al-Saffar; P M Hellström; G Nylander
Journal:  Scand J Gastroenterol       Date:  1985-06       Impact factor: 2.423

7.  Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

Authors:  R M Elliott; L M Morgan; J A Tredger; S Deacon; J Wright; V Marks
Journal:  J Endocrinol       Date:  1993-07       Impact factor: 4.286

8.  PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon.

Authors:  J Wen; S F Phillips; M G Sarr; L J Kost; J J Holst
Journal:  Am J Physiol       Date:  1995-12

9.  Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat.

Authors:  M Giralt; P Vergara
Journal:  Regul Pept       Date:  1998-04-24

10.  Stimulation of truncated glucagon-like peptide-1 release from the isolated perfused canine ileum by glucose absorption.

Authors:  K Sugiyama; H Manaka; T Kato; K Yamatani; M Tominaga; H Sasaki
Journal:  Digestion       Date:  1994       Impact factor: 3.216

View more
  14 in total

1.  [Hormonal and metabolic functions of the small intestine].

Authors:  H Wittenburg; U Tennert; J Mössner
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

Review 2.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

3.  Intraduodenal milk protein concentrate augments the glycemic and food intake suppressive effects of DPP-IV inhibition.

Authors:  Diana R Olivos; Lauren E McGrath; Christopher A Turner; Orianne Montaubin; Elizabeth G Mietlicki-Baase; Matthew R Hayes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-18       Impact factor: 3.619

Review 4.  Enteroendocrine cells: a review of their role in brain-gut communication.

Authors:  R Latorre; C Sternini; R De Giorgio; B Greenwood-Van Meerveld
Journal:  Neurogastroenterol Motil       Date:  2015-12-21       Impact factor: 3.598

Review 5.  The ileal brake: a fifteen-year progress report.

Authors:  G W Van Citters; H C Lin
Journal:  Curr Gastroenterol Rep       Date:  1999-10

Review 6.  Does the Ileal Brake Contribute to Delayed Gastric Emptying After Pancreatoduodenectomy?

Authors:  Savio G Barreto; John A Windsor
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

7.  Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans.

Authors:  C N Andrews; A E Bharucha; M Camilleri; P A Low; B M Seide; D D Burton; K K Nickander; K L Baxter; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2007-09       Impact factor: 3.598

Review 8.  Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing.

Authors:  Catia Sternini; Laura Anselmi; Enrique Rozengurt
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-02       Impact factor: 3.243

9.  Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia.

Authors:  Charlotte J Green; Tora I Henriksen; Bente K Pedersen; Thomas P J Solomon
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

Review 10.  Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function.

Authors:  Chinmay S Marathe; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Exp Diabetes Res       Date:  2011-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.